513 related articles for article (PubMed ID: 6282443)
21. Altered growth and differentiation of cultured mouse epidermal cells infected with oncogenic retrovirus: contrasting effects of viruses and chemicals.
Yuspa SH; Vass W; Scolnick E
Cancer Res; 1983 Dec; 43(12 Pt 1):6021-30. PubMed ID: 6315224
[TBL] [Abstract][Full Text] [Related]
22. Characterization of tumorigenic and metastatic properties of murine sarcoma virus-transformed nonproducer Balb/3T3 cell lines.
Yogeeswaran G; Stein BS; Sebastian H
J Natl Cancer Inst; 1980 Apr; 64(4):951-7. PubMed ID: 6245299
[No Abstract] [Full Text] [Related]
23. In vivo antigenic modification of tumor cells. II. Distribution of virus in sarcoma-bearing mice.
Iglehart JD; Ward EC; Huper G; Thiel K; Bolognesi DP
J Natl Cancer Inst; 1981 Jul; 67(1):117-22. PubMed ID: 6942182
[TBL] [Abstract][Full Text] [Related]
24. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
McDonald TL
J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
[TBL] [Abstract][Full Text] [Related]
25. Deoxyglucose transport of uninfected, murine sarcoma virus-transformed, and murine leukemia virus-infected mouse cells.
Plagemann PG
J Cell Physiol; 1973 Dec; 82(3):421-33. PubMed ID: 4359535
[No Abstract] [Full Text] [Related]
26. Block in the expression of differentiation markers of rat thyroid epithelial cells by transformation with Kirsten murine sarcoma virus.
Fusco A; Pinto A; Tramontano D; Tajana G; Vecchio G; Tsuchida N
Cancer Res; 1982 Feb; 42(2):618-26. PubMed ID: 6275984
[TBL] [Abstract][Full Text] [Related]
27. Non-T-cell-mediated cytotoxicity in mice with tumors induced by Moloney murine sarcoma virus (M-MuSV). II. Granulocyte-mediatd cytotoxicity against autochthonous target cells isolated from M-MuSV-induced tumors.
Becker S; Haskill S
J Natl Cancer Inst; 1980 Aug; 65(2):469-75. PubMed ID: 6249952
[TBL] [Abstract][Full Text] [Related]
28. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
[TBL] [Abstract][Full Text] [Related]
29. Vascular neoplasms induced in rodent central nervous system by murine sarcoma viruses.
Pitts OM; Powers JM; Hoffman PM
Lab Invest; 1983 Aug; 49(2):171-82. PubMed ID: 6308345
[TBL] [Abstract][Full Text] [Related]
30. In vitro growth of an attenuated mouse leukemia virus.
Stefanski E; Kirsten WH
Cancer Res; 1974 Dec; 34(12):3456-60. PubMed ID: 4371964
[No Abstract] [Full Text] [Related]
31. Antibodies to murine leukemia virus gp70 and p15(E) in sera of BALB/c mice immunized with syngeneic chemically induced sarcomas.
Klitzman JM; Brown JP; Hellström KE; Hellström I
J Immunol; 1980 Jun; 124(6):2552-6. PubMed ID: 6246166
[TBL] [Abstract][Full Text] [Related]
32. Sarcoma viruses containing the mos oncogene induce lesions resembling Kaposi's sarcoma.
Stoica G
In Vivo; 1994; 8(1):43-7. PubMed ID: 8054510
[TBL] [Abstract][Full Text] [Related]
33. Microfilaments and intermediate filaments in epithelial cells transformed by murine sarcoma or leukemia viruses.
Keski-Oja J; Lehto VP; Vartio T; Badley RA; Virtanen I
Eur J Cell Biol; 1983 May; 30(2):191-9. PubMed ID: 11596492
[TBL] [Abstract][Full Text] [Related]
34. Malignant transformation and viral replication of rat bone and muscle cells after in vitro infection with rat-adapted murine sarcoma virus (Moloney).
Kano-Tanaka K; Tanaka T; Emura M; Hanaichi T
Cancer Res; 1976 Nov; 36(11 Pt 1):3924-35. PubMed ID: 975041
[TBL] [Abstract][Full Text] [Related]
35. Stage-dependent induction of prenatal tumors in mice by the Kirsten and Moloney strains of murine sarcoma viruses.
Rossi L; Barbieri O; Astigiano S; Ugolini D; Varnier OE
Cancer Res; 1985 Dec; 45(12 Pt 1):6107-12. PubMed ID: 2998593
[TBL] [Abstract][Full Text] [Related]
36. In vivo antigenic modification of tumor cells. I. Introduction of murine leukemia virus antigens on non-virus-producing murine sarcomas.
Iglehart JD; Ward EC; Thiel K; Huper G; Geier SS; Bolognesi DP
J Natl Cancer Inst; 1981 Jul; 67(1):107-15. PubMed ID: 6942181
[TBL] [Abstract][Full Text] [Related]
37. Murine xenotropic type C viruses. IV. Replication and pathogenesis of ducks.
Levy JA; Oleszko O; Dimpfl J; Lau D; Rigdon RH; Jones J; Avery R
J Gen Virol; 1982 Jul; 61 (Pt l)():65-74. PubMed ID: 6288852
[TBL] [Abstract][Full Text] [Related]
38. Metastasizing fibrosarcomas in hamsters (BMH) after injection of B77 sarcoma virus transformed mouse cells.
Sabová L; Smida J; Smidová V
Neoplasma; 1983; 30(6):659-66. PubMed ID: 6318137
[TBL] [Abstract][Full Text] [Related]
39. "Spontaneous" neoplastic transformation in vitro: influence of endogenous murine leukemia virus and serum fractions.
Sanford KK; Handleman SL; Hartley JW; Jackson JL; Gantt RR
J Natl Cancer Inst; 1972 Oct; 49(4):1177-89. PubMed ID: 4343474
[No Abstract] [Full Text] [Related]
40. Cell lines established from (BALB/cx DBA/2)F1 mice which show parent type susceptibility to murine leukemia viruses.
Hoshino H; Yamamoto T
Jpn J Exp Med; 1976 Feb; 46(1):71-7. PubMed ID: 180314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
